MRI of ARPKD liver disease
Contact
Description
The primary goal of this research study is to see if new types of magnetic resonance imaging (MRI) can be used to measure liver health in children with autosomal recessive polycystic kidney disease (ARPKD) compared to healthy controls. Both children with ARPKD and healthy children, aged 6 years and above can participate.
Eligibility and criteria
IRB Number:
20-018367
Eligible age range:
Clinical trial phase:
Pilot
Official title:
What to expect
Related specialties
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.